Swissmedic actions lead to improved local device market surveillance
This article was originally published in Clinica
Swiss competent authority Swissmedic carried out 61 "priority" medical device vigilance actions in 2004, an increase of 50% on the previous year.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.